Ridgecrest Wealth Partners
ABBV icon

Ridgecrest Wealth Partners’s AbbVie ABBV Stock Holding History

Ridgecrest Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.18M Sell
8,337
-2
-0% -$513 1.01% 20
2026
Q2 		$2.1M Buy
8,339
+1
+0% +$215 1.01% 21
2026
Q1 		$1.81M Hold
8,338
– – 1% 23
2025
Q4 		$1.91M Buy
8,338
+86
+1% +$19.6K 1.03% 23
2025
Q3 		$1.91M Buy
8,252
+2
+0% +$407 0.86% 25
2025
Q2 		$1.53M Sell
8,250
-3
-0% -$558 0.81% 29
2025
Q1 		$1.73M Buy
8,253
+350
+4% +$68K 0.91% 26
2024
Q4 		$1.4M Hold
7,903
– – 0.76% 28
2024
Q3 		$1.56M Buy
7,903
+198
+3% +$37K 0.81% 24
2024
Q2 		$1.32M Buy
7,705
+34
+0.4% +$5.63K 0.8% 27
2024
Q1 		$1.4M Hold
7,671
– – 0.83% 27
2023
Q4 		$1.19M Sell
7,671
-519
-6% -$75.7K 0.79% 31
2023
Q3 		$1.22M Hold
8,190
– – 0.86% 28
2023
Q2 		$1.1M Hold
8,190
– – 0.73% 28
2023
Q1 		$1.31M Hold
8,190
– – 0.93% 24
2022
Q4 		$1.32M Hold
8,190
– – 1.01% 24
2022
Q3 		$1.1M Sell
8,190
-3,150
-28% -$452K 0.9% 26
2022
Q2 		$1.74M Hold
11,340
– – 1.26% 22
2022
Q1 		$1.84M Hold
11,340
– – 1.17% 20
2021
Q4 		$1.54M Buy
11,340
+74
+0.7% +$8.74K 0.75% 32
2021
Q3 		$1.22M Buy
11,266
+576
+5% +$65.8K 0.66% 36
2021
Q2 		$1.2M Buy
10,690
+2,400
+29% +$270K 0.75% 35
2021
Q1 		$897K Buy
+8,290
New +$887K 0.86% 37

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Ridgecrest Wealth Partners's ABBV Position: Q3 2026 in Review

Ridgecrest Wealth Partners reduced its AbbVie (ABBV) stake by 0.02% in Q3 2026, selling an estimated $513 and leaving 8,337 shares worth $2.18M. The position accounts for 1.01% of the portfolio, ranked #20.

Ridgecrest Wealth Partners first reported a position in ABBV in Q1 2021 and has held it in 23 quarters since. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Ridgecrest Wealth Partners held 8,337 shares of AbbVie worth $2.18M as of Q3 2026.
  • Ridgecrest Wealth Partners sold 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 1.01% of Ridgecrest Wealth Partners's portfolio in Q3 2026, its #20 holding.
  • Ridgecrest Wealth Partners first reported a position in AbbVie in Q1 2021 and has held it in 23 quarters since.
  • 3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ridgecrest Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.